Willett J, Waqas M, Choi Y, Ngai T, Mullin K, Tanzi R
Alzheimers Dement. 2025; 21(2):e14592.
PMID: 39998322
PMC: 11852348.
DOI: 10.1002/alz.14592.
Ding M, Schmidt-Mende K, Modig K
JAMA Netw Open. 2025; 8(2):e2461117.
PMID: 39982724
PMC: 11846011.
DOI: 10.1001/jamanetworkopen.2024.61117.
Stoeckel L, Fazio E, Hardy K, Kidwiler N, McLinden K, Williams B
Alzheimers Dement (N Y). 2025; 11(1):e70058.
PMID: 39975465
PMC: 11837731.
DOI: 10.1002/trc2.70058.
Mendizabal A, Ogilvie A, Bordelon Y, Perlman S, Brown A
Neurol Clin Pract. 2025; 14(5):e200344.
PMID: 39872293
PMC: 11771962.
DOI: 10.1212/CPJ.0000000000200344.
Ruggiano N, Brown E, Clarke P, Hristidis V, Roberts L, Framil Suarez C
JMIR Aging. 2024; 7:e57308.
PMID: 39727199
PMC: 11684532.
DOI: 10.2196/57308.
Mobility-Based Smartphone Digital Phenotypes for Unobtrusively Capturing Everyday Cognition, Mood, and Community Life-Space in Older Adults: Feasibility, Acceptability, and Preliminary Validity Study.
Hackett K, Xu S, McKniff M, Paglia L, Barnett I, Giovannetti T
JMIR Hum Factors. 2024; 11:e59974.
PMID: 39576984
PMC: 11624463.
DOI: 10.2196/59974.
Modeling the Population Equity of Alzheimer Disease Treatments in the US.
Synnott P, Majda T, Lin P, Ollendorf D, Zhu Y, Kowal S
JAMA Netw Open. 2024; 7(10):e2442353.
PMID: 39480421
PMC: 11528311.
DOI: 10.1001/jamanetworkopen.2024.42353.
Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers.
Kulshreshtha A, Parker E, Fowler N, Summanwar D, Miled Z, Owora A
JAMA Netw Open. 2024; 7(10):e2440411.
PMID: 39436648
PMC: 11581540.
DOI: 10.1001/jamanetworkopen.2024.40411.
A scoping review of the unique landscape and challenges associated with dementia in the Western Pacific region.
Devenney E, Anh N Nguyen Q, Tse N, Kiernan M, Tan R
Lancet Reg Health West Pac. 2024; 50:101192.
PMID: 39399870
PMC: 11471059.
DOI: 10.1016/j.lanwpc.2024.101192.
Identification of 16 novel Alzheimer's disease susceptibility loci using multi-ancestry meta-analyses of clinical Alzheimer's disease and AD-by-proxy cases from four whole genome sequencing datasets.
Willett J, Waqas M, Choi Y, Ngai T, Mullin K, Tanzi R
medRxiv. 2024; .
PMID: 39314934
PMC: 11419201.
DOI: 10.1101/2024.09.11.24313439.
Identification of amnestic mild cognitive impairment among Black and White community-dwelling older adults using NIH Toolbox Cognition tablet battery.
Rigby T, Gregoire A, Reader J, Kahsay Y, Fisher J, Kairys A
J Int Neuropsychol Soc. 2024; 30(7):689-696.
PMID: 39291413
PMC: 11486605.
DOI: 10.1017/S1355617724000213.
Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare.
Gianattasio K, Wachsmuth J, Murphy R, Hartzman A, Montazer J, Cutroneo E
JAMA Netw Open. 2024; 7(9):e2427610.
PMID: 39226058
PMC: 11372506.
DOI: 10.1001/jamanetworkopen.2024.27610.
Identification of older adults with Alzheimer's and related dementias among patients newly diagnosed with cancer: A comparison of methodological approaches.
Keeney T, Miller A, Gilissen J, Coombs L, Ritchie C, McCarthy E
J Geriatr Oncol. 2024; 15(7):101842.
PMID: 39122573
PMC: 11411497.
DOI: 10.1016/j.jgo.2024.101842.
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease.
Howe M, Britton K, Joyce H, Menard W, Emrani S, Kunicki Z
Alzheimers Res Ther. 2024; 16(1):154.
PMID: 38971815
PMC: 11227160.
DOI: 10.1186/s13195-024-01521-9.
Correlates of missed or late versus timely diagnosis of dementia in healthcare settings.
Chen Y, Power M, Grodstein F, Capuano A, Lange-Maia B, Moghtaderi A
Alzheimers Dement. 2024; 20(8):5551-5560.
PMID: 38934297
PMC: 11350028.
DOI: 10.1002/alz.14067.
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease.
Howe M, Britton K, Joyce H, Menard W, Emrani S, Kunicki Z
Res Sq. 2024; .
PMID: 38853872
PMC: 11160917.
DOI: 10.21203/rs.3.rs-3755419/v1.
2024 Alzheimer's disease facts and figures.
Alzheimers Dement. 2024; 20(5):3708-3821.
PMID: 38689398
PMC: 11095490.
DOI: 10.1002/alz.13809.
Alzheimer's Disease and Related Dementias Diagnosis in the United States Among US-Born and Foreign-Born White, Black, Hispanic, and Asian Older Adults.
Kindratt T, Zahodne L, Dallo F, Ajrouch K
J Racial Ethn Health Disparities. 2024; .
PMID: 38668780
PMC: 11511784.
DOI: 10.1007/s40615-024-02014-z.
Comorbid Conditions Are Associated With Cognitive Impairment in Native Hawaiians and Pacific Islanders.
McEligot A, Pang K, Moran-Gomez S, Mitra S, Santos M, Tahmasebi Z
Int J Aging Hum Dev. 2024; 99(4):420-433.
PMID: 38327065
PMC: 11303594.
DOI: 10.1177/00914150241231186.
Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review.
Hinton L, Tran D, Peak K, Meyer O, Quinones A
Alzheimers Dement. 2024; 20(4):3000-3020.
PMID: 38265164
PMC: 11032576.
DOI: 10.1002/alz.13612.